Interim Report - Health Products Stewardship Association

Transcription

Interim Report
on the
Ontario Medications Return Program
and the
Ontario Sharps Collection Program
for the period of
Oct 1, 2012 – March 31, 2013
Prepared by:
Ginette Vanasse
Executive Director,
Health Products Stewardship Association
330-2255 St. Laurent Blvd.
Ottawa, ON K1G 4K3
613-723-7282
September 13th , 2013
Contents
1.
Program Outline.................................................................................................................................... 3
a) Pharmaceuticals and Natural Health Products ...................................................................................... 3
b) Sharps ................................................................................................................................................... 4
c) Producers .............................................................................................................................................. 4
d) Collection Sites ..................................................................................................................................... 4
2. Actions Taken and Outcomes Achieved by HPSA ................................................................................... 6
3. Public Education Materials and Strategies.............................................................................................. 10
a) Consumer Information ........................................................................................................................ 10
b) Pharmacy Information ........................................................................................................................ 10
c) Member Information ........................................................................................................................... 10
d) Other Resources.................................................................................................................................. 10
4. Collection System ................................................................................................................................... 11
a) Product Collected................................................................................................................................ 11
b) Collection Locations ........................................................................................................................... 11
c) Ontario Medications Return Program ................................................................................................. 11
d) Ontario Sharps Collection Program .................................................................................................... 12
Appendix 1 a): HPSA Members – Medications.................................................................................... 14
Appendix 1 b): HPSA Members – Sharps .............................................................................................. 17
Appendix 2 Promotional and Educational Material .................................................................................... 18
Appendix 3: Public Waste Protocol / Agreement ....................................................................................... 19
Appendix 4: HPSA list of registered pharmacies ....................................................................................... 23
Appendix 5:................................................................................................................................................. 23
List of accredited pharmacies from the Ontario College of Pharmacists .................................................... 23
Appendix 6 - Addendum to Interim Report
Appendix 7. Promotion and Education
Appendix 8. Collection Summary
Ontario Interim Report June 2013 with addendum
Page 2.
1. Program Outline
The Health Products Stewardship Association (HPSA) is the industry funding organization (IFO) created
to manage the end of life of expired health products returned from the public in regulated provincial
programs. HPSA's producer members represent the majority of brand-owners selling health products in
Canada. The lists of producers for pharmaceuticals and for sharps that are members of the HPSA and are
participating in the Ontario Medications Return Program (OMRP) and the Ontario Sharps Collection
Program (OSCP) are attached in Appendix 1a and 1b.
The OMRP and the OSCP address EPR for all types of pharmaceuticals/sharps sold for use in the province
of Ontario but is limited to the “consumer” waste stream. The programs are designed to ensure that
collection service is available to all regions of the province and all returned products/devices are
packaged, handled, stored, transported and disposed of in a safe, compliant and environmentally
responsible manner.
The compliance requirements of both programs are dictated primarily by Regulation 298/12 “Collection
of Pharmaceuticals and Sharps – Responsibilities of Producers”. This regulation requires producers of
pharmaceuticals and sharps to provide for the collection and safe environmental management of their
leftover products from consumers. Producers must also provide Ontarians with access to free and
convenient collection locations, such as retail pharmacies, to return their leftover pharmaceuticals and
sharps.
a) Pharmaceuticals and Natural Health Products
The regulation defines “pharmaceutical” as:
“a drug within the meaning of section 2 of the Food and Drugs Act (Canada) that is sold to
consumers in Ontario, whether it is sold by the producer of the pharmaceutical or by another
person, and includes a natural health product within the meaning of the Natural Health Products
Regulations made under that Act”
For the purposes of the OMRP, a pharmaceutical does not include the following:
a) A substance or mixture of substances manufactured, sold or represented for use in disinfection
in premises in which food within the meaning of section 2 of the Food and Drugs Act (Canada) is
manufactured, prepared or kept.
b) A food within the meaning of section 2 of the Food and Drugs Act (Canada).
c) A cosmetic within the meaning of section 2 of the Food and Drugs Act (Canada).
d) Any of the following items, if the item does not contain a substance prescribed under the Drug
and Pharmacies Regulation Act as being included in Schedule I established by the regulations
made under that Act:
 A contact lens disinfectant.
 An anti-dandruff product, including shampoo.
 An anti-perspirant.
Ontario Interim Report June 2013
Page 3.






A sunburn protectant.
A mouthwash.
A fluoridated toothpaste.
A lozenge for cough, sore throat or halitosis.
A topical substance that does not contain antibiotics or anti-fungal agents.
A radiopharmaceutical.
b) Sharps
The regulation defines “Sharps” as:
“A needle, safety engineered needle, lancet or other similar instrument that is designed to
puncture the skin of individuals or companion animals for medical purposes and that is sold to
consumers in Ontario, whether it is sold by the producer of the sharps or another person, and
includes anything affixed to the sharp, including a syringe”.
c) Producers
The regulation defines “Producers” as:
a) the manufacturer of the pharmaceutical or sharp, if it is sold to consumers in Ontario under a
brand that the manufacturer owns, licenses or otherwise has rights to;
b) if there is no person described in clause (a), the owner or licensee of the brand or the person
who otherwise has rights to the brand under which the pharmaceutical or sharp is sold to
consumers in Ontario;
c) if there is no person described in clause (a) or (b), the importer of the pharmaceutical or sharp
into Ontario; or
d) if there is no person described in clause (a), (b) or (c), the first person who sells the
pharmaceutical or sharp to another person in Ontario.
d) Collection Sites
Retail pharmacies participating in either the OMRP and/or the OSCP must have a registered pharmacist
or registered pharmacy technician that is trained on how to receive, handle and package waste returned
to the pharmacy by consumers.
Since the voluntary participation of a pharmacist or pharmacy technician is central to the success of the
program, HPSA works closely with them to ensure full participation and awareness of both programs.
Pharmacy managers interested in offering the program in their store must complete a registration form.
Specific information is provided to ensure that pharmacy managers and staff are knowledgeable on the
program objective and the way the program operates. All participating collection locations receive a kit
Page 4.
containing instructions on the program, a service request form, and sample of education material
developed for this program along with pharmaceutical waste containers clearly identified with the MRP
symbol and a Steri-pack for securely storing used sharps for disposal. Once the registration form is
completed and submitted to HPSA, the pharmacist is contacted directly by the program administrator to
review the specific information for each program.
Page 5.
2. Actions Taken and Outcomes Achieved by HPSA
Products
Pharmaceuticals and Sharps
Section:
2. “A Producer of a pharmaceutical shall provide for…..”
Action Required
Action Taken
Outcome
2.1 “The collection of the
pharmaceutical at collection
locations from consumers who
bring the pharmaceutical to the
collection locations.”
A producer funded collection network has been
established and is administered by the IFO, HPSA
The network is up and running as of October 1,
2012.
Ready
2.2 “The disposal of the
pharmaceutical.”
Stericycle, ULC. has the required ECA’s in place
for transporting and disposing of pharmaceuticals
and their primary packaging. Stericycle, ULC.
been contracted by HPSA on behalf of producers
to dispose of all pharmaceuticals and the
containers the pharmaceuticals are in that are
brought to the collection locations by consumers.
In place
2.3 “The collection, and the
recycling or disposal, of containers
in which consumers bring the
pharmaceutical to collection
location and that have come into
direct contact with the
pharmaceutical.
Section:
In place
3.(1) “The producer of a sharp shall provide for….”
3.1 “The collection of the sharps at
the collection locations from
consumers who bring the sharp to
the collection locations.”
A producer funded collection network has been
established and is administered by the IFO, HPSA
The network is up and running as of October 1,
2012.
Ready
3.2 “The disposal of the sharp.”
Stericycle, ULC. has the required ECA’s in place
for transporting and disposing of sharps and
sharps containers in which consumers bring used
sharps to collection locations. Stericycle, ULC.
been contracted by HPSA on behalf of producers
to dispose of all sharps and sharps containers
brought to collection locations by consumers
In place
3.3 “The collection and disposal of
containers designed for the safe
handling of sharps in which
consumers bring the sharp to the
collection locations.
Section:
Ready
4. (1) “Subject to subsection (2), a producer of a pharmaceutical or sharp shall ensure
that the number of collection locations at which collection of the designated material of
the producer is provided in a calendar year is, at a minimum, the lesser of the
following;”
4. (1) 1 “The number equal to 80%
of all retail locations in Ontario, as
of October 1 in the preceding
calendar year, at which a
As of March 31, 2013” there were 2,962
pharmacies actively participating in the
programs.
Exceeded
The
participation
Page 6.
pharmaceutical or sharp was sold.”
4. (1).2 “The number equal to 80%
of pharmacies in Ontario, as of
October 1 in the preceding
calendar year, in respect of which a
certificate of accreditation is in
effect under section 130 of the
Drug and Pharmacies Regulation
Act, as set out by the Director on
the internet through the Ministry’s
website.”
4 (2) “A producer of a
pharmaceutical or sharp shall
ensure that there is at least one
collection location at which
collection of the designated
material of the producer is
provided for in each local
municipality in Ontario in which
there is a retail location at which
the pharmaceutical or sharps is
sold.”
Section:
An HPSA assessment determined that 3,524
registered pharmacies were eligible to
participate in the OSCP and OMRP programs.
rate of total
eligible
pharmacy
collection
locations in the
combined
programs in
Ontario was
84%.
HPSA has reviewed the list of participating
collection locations and determined there is at
least one collection location in every municipality
in Ontario except in Moosonee, Hagarty and
Richards, and Township of Nairn.
In Progress
HPSA is reaching out to community pharmacies
in these municipalities to ensure participation.
4. (3)“A producer of a pharmaceutical or sharp shall ensure that at each collection
location at which the producer provides for collection of the designated material of the
producer, the collection is,”
4. (3) (a) “available free of charge
to consumers”
This is a free value add service to bring traffic into
retail pharmacies particularly from high dollar
value customers like diabetics.
Ready
4. (3) (b) “not subject to any
limitations with respect to the
quantity of the designated material
of the producer that a consumer
may bring for collection; and”
Space in retail pharmacy is limited which limits
the ability to accept large quantities of containers
(+2) but this constraint is managed by having
retail pharmacy locations on a regularly
scheduled pickup.
In Place
4. (3) (c) “if the collection location
is in a pharmacy in respect of
which a certificate of accreditation
is in effect under section 139 of the
Drug and Pharmacies Regulation
Act, available during the business
hours of the pharmacy.”
List of accredited pharmacies obtained from the
Ontario College of Pharmacists’ has been
analyzed and the eligible collection locations
have been determined.
Achieve
Section:
5. (1) “Section 27 of the Act does not apply with respect to the collection, handling,
Page 7.
storage and transfer of pharmaceuticals, sharps and containers at a collection location
that are collected for the purposes of one or both of section 2 and 3 if,”
5. (1) (a) “an agreement that meets
the requirements set out in section
6 is in effect with respect to the
collection location; and
Each pharmacy has to sign a Public Waste
Protocol / Agreement (see Appendix 3) between
the pharmacy and Stericycle before they can
participate in the HPSA programs
In place
5. (1) (b) “a person registered as a
pharmacist under the Pharmacy
Act, 1991 or a person registered as
a pharmacy technician under that
Act is present when the collection
is offered
This is a requirement of the Public Waste
Protocol / Agreement
In place
5. (2), 5. (3), 5. (4)
HPSA is compliant with sections 5.1 (a) and (b)
therefore compliant with sections 5.2, 5.3 and 5.4
In place
Section
6. (2) “For the purposes of section 5, the agreement shall meet the following
requirements
6. (2).1 i. and ii
This compliance requirement is addressed in 5.1
a
Complete
6. (2) 2 “The agreement shall
address the following, at a
minimum, in respect of each
collection location to which it
applies:
Each pharmacy has to sign a Public Waste
Protocol / Agreement outlining the points in 6.2.2
I and ii HPSA will provide the Ministry of the
Environment with copies of all educational and
promotional material used to support the Ontario
Sharps Collection Program and the Ontario
Medications Return Program
Complete
Instruction pamphlet for pharmacy staff is
available to address annual training
requirements. The Public Waste Protocol /
Agreement addresses the annual training
requirement.
Complete
i) The types of containers that are
to be used for collecting, handling
and storing the pharmaceuticals,
sharps and containers and the
manner in which the containers
used for collecting, handling and
storing are to be labelled.
ii) Procedures in respect of how the
pharmaceuticals, sharps and
containers collected are to be
collected, handled and stored,
including the manner in which they
are to be segregated from each
other.”
6. (2) 3 “The agreement shall
include a requirement that persons
collecting, handling and storing
pharmaceuticals, sharps or
containers collected for the
purposes of one or both of sections
Page 8.
2 and 3 receive annual training
with respect to the safe collection,
handling and storage and the
requirements of the agreement”
6. (3) “ The operator of the
collection location shall ensure that
a copy of the agreement and any
related records are retained at the
collection location during the time
period when the agreement
applies and the following five-year
period”
Section:
HPSA provides an educational brochure to
pharmacies about the collection, handling and
storage requirements of returned medications
and used sharps to fulfill the annual training
requirements.
In place
7. (1) “A producer of a pharmaceutical or sharps shall ensure that the following
information is made available publically and free of charge
7. (1) 1 “The location of collection
locations at which collection of the
designated material of the
producer is provided for”
Database of collection locations is up and
searchable on the HPSA website
In place
7. (1) 2 “The information described
in subsection (1) shall, at a
minimum, be made available,
HPSA has notified its members on this
requirement
Further Action
Required
a) on the internet through the
producer’s web site; and
b) in print at each collection
location at which collection of the
designated material of the
producer is provided for.”
Section:
For small producers with no web site, HPSA will
act collectively on their behalf to fulfill the web
site information requirement by having the small
producer contact profile listed on the HPSA web
site. A search engine optimization strategy will
also be deployed to enhance search engine
placement of small producers listed on the HPSA
web site.
8. (2) “A report required under subsection (1) may be prepared on behalf of more than
one producer of pharmaceuticals and sharps and, if this is done, the report shall set out,
at a minimum, the following information:”
8. (2) 1 “The name of each
producer on behalf of whom the
report is prepared.”
List of producer members is found in Appendix 1
a) and 1 b)
Complete
8.(2) 2 “A description of actions
taken and outcomes achieved by
the producers in respect of the
requirements of the regulation”
Interim report
Complete
8. (2) 3 “The report shall be made
available publically and free of
charge on the internet through the
producer’s website for a minimum
of one year
Posted on HPSA website
In place
Page 9.
3. Public Education Materials and Strategies
a) Consumer Information
The following information about the OMRP and the OSCP is available to consumers:


Brochures: Information on the safe use and storage of products in the form of two panel
brochures entitled “Don’t Throw It Out” and Take-it Back” have been developed. Consumers can
request them by, fax, email or through the HPSA website, free of charge in English and/or
French.
Bookmarks: These are provided to groups/organizations interested in promoting the program
to the public such as clinics, doctor’s offices or for special events like “National Prescription
Drop-off Day”.
b) Pharmacy Information
The following information about the OMRP and the OSCP is available to pharmacies:



Brochures: A three panel easy to read brochure containing information for the pharmacy staff
on each program.
Window Decal: Signage developed for participating pharmacy\ies to promote the program.
News bulletin: A bi-annual e-bulletin with information for pharmacies registered in the
programs.
c) Member Information
The following information about the OMRP and the OSCP is available to producer members:
News bulletin: This is issued on a quarterly basis to HPSA members in addition to the bi-annual ebulletin for the pharmacies registered in the programs.
d) Other Resources

Web Site: The HPSA website provides the public with information on the location of collection
sites for the disposal of medications or sharps. Within the site is a searchable database of
pharmacies and an explanation of products accepted by the programs.
Page 10.

Links: As we continue to build our membership base, members are encouraged to promote the
OMRP and the OSCP on their web site via a link to the HPSA website
Examples of promotional and educational material for the programs are attached in Appendix 2.
4. Collection System
a) Product Collected
2012 - Monthly Kgs
Designated
Material
Sharps
Cytotoxic Sharps
Medications
Oct
15,242
843
27,525
Nov
16,765
945
26,743
Dec
12,686
823
21,226
2013 - Monthly Kgs
Jan
18,780
979
32,131
Feb
14,041
831
25,056
Mar
15,144
665
26,126
b) Collection Locations
Retail pharmacies participating in the programs must have a registered pharmacist or registered
pharmacy technician that is trained on how to receive, handle and store medications/ sharps waste
returned to the pharmacy by consumers. Since the voluntary participation of a pharmacist is central to
the success of the program, HPSA works closely with them to ensure full participation and good
knowledge on the program objectives and the way the programs operates.
Pharmacy managers interested in offering the program in their store must complete a registration form.
Specific information is provided to ensure that pharmacy managers and staff are well aware on how to
handle either material returned by the public. All participating collection locations receive a kit
containing instructions on the program, a service request form, and sample of education material
developed for this program along with a Steri-pack. Once the registration form is completed and
submitted to HPSA, the pharmacist is contacted directly to review the following information
c) Ontario Medications Return Program
The collection sites for the OMRP are community pharmacies. Registered pharmacy locations are easily
identified through a web-based search engine on the HPSA website. Pharmacies are a logical and safe
system for the public to return unused or expired medications. Many are open extended hours, offering
a convenient place for consumer disposal year-round.
Since the voluntary participation of a pharmacist is central to the success of this program, we work
closely with our partners to ensure full participation and awareness of industry program for returning
unused medications to the pharmacy.
Pharmacy managers interested in offering the OMRP in their store must complete a registration form.
Specific information is provided to ensure that pharmacy managers and staff are knowledgeable on the
Page 11.
program objective and the way the program operates. All participating community pharmacies receive a
kit containing instructions on the program, service request form, and sample of education material
develop for this program with 2 containers. Once the registration form is completed and faxed to our
office, the pharmacist is contacted by phone to discuss the following points:




The program is for returns from the public and not from hospitals, institutions, doctor’s offices
or their own operations.
All employees working at the site must be knowledgeable about the program offered to the
public.
All pills should be deposited into the container and the original package should be recycled
except for liquid medications, gels, powder, etc. Containers should be deposited directly into
the container
To recycle the outer container/ extra packaging where facilities exists and available in their
region.
Once two containers are full, the pharmacist must complete the service request form and contact the
service provider to schedule service. Replacement containers will be delivered and the full container will
be picked up either on s service schedule or by request.
d) Ontario Sharps Collection Program
Biomedical sharps are sharps products used by consumers that are designed to puncture the skin for
medical purposes and must be properly placed in an approved sharps container, color coded yellow with
a universal biohazard symbol on the outside, with a lid that is sealed shut in order to be accepted at
collection locations. At the pharmacy the sharps containers must then be placed into approved
secondary containment packaging in the form of a corrugated cardboard box with the universal
biohazard symbol on the outside and lined with a 2 mil plastic bag. Once the full sharps containers are
placed into the lined box it is sealed shut and ready for transportation and disposal.
When a prescription is filled for a cytotoxic medication that has a sharp, the lead practice is to provide
a new sharps container with a cytotoxic label to the customer at the same time. Cytotoxic sharps are
sharps products used by consumers for a chemotherapeutic application and must be placed in an
approved sharps container, with the cytotoxic symbol on the outside and a lid that is sealed shut in
order to be accepted at collection locations. These containers must then be placed into approved
secondary containment packaging in the form of a corrugated cardboard box with the universal
biohazard symbol on the outside and a cytotoxic label prominently displayed on the outside of the box.
The box should have a 2 mil plastic liner. Once the full sharps containers are placed into the lined box it
is sealed shut and ready for transportation and disposal.



Sharps from hospitals, institutions, doctor’s offices or internal pharmacy operations are not
acceptable.
All employees working at the collection location must be knowledgeable about the program
offered to consumers.
The pharmacy shall only receive sharps in a hard-shell container (approved sharps container)
which is labelled with the universal biohazard symbol.
Page 12.





Sharps containers must be segregated from waste pharmaceuticals.
Sharps approved containers are placed in a cardboard box with yellow liner.
Sharps used to administer cytotoxic drugs shall be deposited into a sharps container and labelled
with a cytotoxic label.
The pharmacist or pharmacy technician will inform sharps user on the proper disposal of needles.
Upon receiving sharps containers, pharmacists should ensure that tops of the containers are
securely closed and placed face down in the Steri-pack.
Page 13.
Appendix 1 a): HPSA Members – Medications
Company Name
AA Pharma Inc.
Abbott Laboratories Limited
Abbott Diabetes Care
Actelion Pharmaceuticals Canada Inc.
Advantage Sales and Marketing Canada
Alcon Canada Inc.
Amgen Canada Inc.
Amway Canada Corporation
Apotex Inc.
Aptalis Pharma Canada Inc.
Astellas Pharma Canada Inc.
AstraZeneca Canada Inc.
Auto Control Medical
Aventix Animal Health
Baxter Canada
Bayer HealthCare, Consumer Care
Bayer Inc.
Bimeda-MTC Animal Health Inc.
Bioforce Canada Inc.
Biogen Idec Canada Inc
Bioniche Animal Health Canada
Boehringer Ingelheim Canada Ltd.
Bristol-Myers Squibb Pharmaceutical Group
Canada Safeway Ltd.
Champion Alstoe Animal Health Inc.
Cobalt Pharmaceuticals Inc.
Combe Incorporated
Costco
Covidien
Cytex Pharmaceutical Inc.
Domrex Pharma Inc.
Elanco
Eli Lilly Canada Inc.
EMD-Serono Canada Inc.
Enzymatic Therapy
Ferring Inc.
Galderma Canada
General Nutrition Centres Canada
GlaxoSmithKline Consumer Healthcare Inc.
GlaxoSmithKline Inc.
Helix BioPharma Corp.
Web site
www.aapharma.ca
www.abbott.ca
www.abbott.ca
www.actelion.com
www.asmnet.com
www.alconlabs.com/ca_en/
www.amgen.com
www.amway.ca
www.apotex.com/ca/en/
www.aptalispharma.com
www.astellas.com/ca/
www.astrazeneca.ca
www.aventix.ca
www.baxter.com/
www.bayerhealth.com
www.bayer.ca
www.bimeda.com
www.bioforce.ca
www.biogenidec.com/
wwwbionicheanimalhealth.com
www.boehringer-ingelheim.ca
www.bmscanada.ca
www.safeway.com
www.championalstoe.com
www.cobaltpharma.com/
www.combe.com
www.costco.ca
www.covidien.com
www.cytex.com
www.lilly.ca
www.emdserono.ca
www.enzymaticcanada.com
www.ferring.com/
www.galderma.ca
www.gnc.com
www.gsk.com
www.gsk.com
www.helixbiopharma.com
Page 14.
Herbalife of Canada
Hospira Healthcare Corporation
HPI Health Products/Lakota
Intervet Canada Corp (dba Merck Animal Health)
Institut Rosell-Lallemand
Jamieson Laboratories
Janssen Inc.
Johnson & Johnson Inc.
Katz Group Canada Ltd
Kripps Pharmacy
Laboratoires Atlas
Leo Pharma Inc.
LifeScan Canada Inc.
Loblaw Companies Ltd
London Drugs Limited
Lundbeck Canada Inc.
Mannatech Incorporated
Medicopia Life Sciences Inc.
Merck Canada Inc.
Merial Canada Inc.
Mint Pharmaceuticals Inc
Mylan Canada
Natural Factors Nutritional Products Ltd.
Nature's Sunshine Products of Canada Ltd.
Nature's Way Canada Ltd
Norbrook Laboratories Inc.
Novartis Consumer Health Canada Inc.
Novartis Pharma Canada Inc.
Novo Nordisk
Odan Laboratories Ltd.
Omega Alpha Pharmaceuticals
Omega Laboratories Ltd.
Organika Health Products Inc.
Overwaitea Food Group Ltd Partnership
Paladin Labs Inc.
PendoPharm, a Division of Pharmascience Inc.
Peoples Drug Mart (B.C.) Ltd
Pfizer Animal Health
Pfizer Canada Inc
Pfizer Consumer Healthcare, Division of Pfizer Canada
Inc.
Pharmaceutical Partners of Canada Inc.
Pharmasave Drugs (National) Ltd.
Pharmascience Inc.
Platinum Naturals
www.herbalife.com
www.lakotaherbs.com/
www.merck-animal-health.ca/
www.institut-rosell.com
www.jamiesonvitamins.com
www.janssen-ortho.com
www.jnjcanada.com
www.katzgroup.ca
www.krippspharmacy.com
www.leo-pharma.com
http://onetouch.ca
www.londondrugs.com
www.lundbeck.ca
http://ca.manatech.com
www.glgcommunications.com
www.merck.ca
www.mylan.ca
www.naturalfactors.com
www.naturesunshine.ca
www.naturesway.com
www.norbrook.com
www.novartis.ca
www.novartis.ca
www.novonordisk.com
www.odanlab.com
www.omegaalpha.ca
www.omegalaboratory.com
www.organika.com
www.paladin-labs.com
www.pharmascience.com
www.peoplesdrugmart.com
www.pfizer.ca
www.pfizer.ca
www.pfizer.ca
www.pharmasave.com
www.pharmascience.com
www.platinumnaturals.com
Page 15.
Procter & Gamble Inc.
ProMedics Nutraceutical Ltd
Purdue Pharma
Rafter 8 Products
Ranbaxy Pharmaceuticals Canada Inc.
Reckitt Benckiser (Canada) Inc.
Reckitt Benckiser Pharmaceuticals Inc.
Roche Limited
Sanis Health Inc.
Sanofi-Aventis
Sanofi Consumers Health
Schering-Plough Canada Inc.
Seaford Pharmaceuticals Inc.
Servier Canada Inc.
Shaklee Canada Inc.
Shire Canada Inc.
Shoppers Drug Mart, Pharmaprix
SISU Inc.
Stericycle Inc.
Stiefel Canada Inc., a GSK Company
Sunovion Pharmaceuticals Inc.
Takeda Canada Inc.
Target Canada
Taro Pharmaceuticals Inc.
Teva Canada / Novopharm
Triton Pharma Inc.
Trophic Canada
UniPHARM Wholesale Drugs
USANA Canada Co.
Valeant Canada Limited
Vetoquinol Canada Incorporate
Virbac Animal Health Canada
Vita Health Products Inc.
W.F. Young, Inc.
Wal-Mart Canada Corp.
Warner Chilcott Canada Co.
Webber Naturals Ltd.
WellSpring Pharmaceutical Canada Corp.
Westcoast Naturals
WN Pharmaceuticals Ltd.
www.pg.com
www.promedics.ca
www.purdue.ca
www.rafter8products.ca
www.ranbaxy.com
www.reckittbenckiser.com
www.suboxone.com
www.rochecanada.com
www.sanis.com/
www.aventispharma.ca
www.schering-plough.ca
www.seaford.ca
www.servier.com
www.shaklee.ca
www.shire.com
www.shoppersdrugmart.ca
www.sisu.com
www.stericycle.com
www.stiefel.ca
www.sunovionrpharma.ca
www.takedacanada.com
www.target.com
www.taro.ca
www.tevacanada.com
www.Tritonpharma.ca
www.trophic.net
www.unipharm.com
www.usana.com
www.valeant.com
www.vetoquinol.ca
www.virbac.ca
www.vitahealth.ca
www.wfyoung.com
www.walmart.com
www.pgpharma.com
www.webbernaturals.com
www.wellspringpharm.com
www.westcoastnaturals.com
Page 16.
Appendix 1 b): HPSA Members – Sharps
Company Name
Abbott Diabetes Care
Abbott Laboratories Ltd.
Amgen Canada Inc.
AstraZeneca
Auto Control Medical
Baxter Canada
Bayer Inc.
Becton Dickenson Medical
Biogen Idec Canada Inc.
Bristol Myers Squibb Pharmaceutical Group
Covidien Kendall
Domrex Pharma Inc.
Eli Lilly Canada Inc.
EMD-Serono Canada Inc.
Ferring Inc.
GlaxoSmithKline Inc.
Hospira Healthcare Corp.
Intervet Canada Corp (dba Merck Animal Health)
Janssen Inc.
Leo Pharma Inc.
Lifescan Canada Inc.
Medtronic
Merck Canada Inc.
Novartis Pharma Canada Inc.
Novo Nordisk
Paladin Labs Inc.
Pfizer (Wyeth)
Pharmascience Inc.
Roche Diabetes Care
Sanofi-Aventis
Schering-Plough Canada Inc.
Stericycle, ULC.
Teva Canada
Valeant Canada LP
Wal-Mart Canada Corp.
Page 17.
Appendix 2 Promotional and Educational Material
Page 18.
Appendix 3: Public Waste Protocol / Agreement
Page 19.
Page 20.
Page 21.
Page 22.
Appendix 4: HPSA list of registered pharmacies
Separate document
Appendix 5:
List of accredited pharmacies from the Ontario College of Pharmacists
Separate document
Page 23.
Appendix 6 - Addendum to Interim Report
Promotion and Education section 7. (1) EPA 298/12
Activities completed by HPSA on behalf of producers related to consumers, pharmacies and products
collected for the period from April 1st to June 30th 2013.
Consumers:
•
Brochures and bookmarks (appendix 7a) are available in French and English for the consumers.
These easy to read brochures provide information on the safe use and storage of products
(medications and sharps devices).
•
Door stickers at retail. Signage for participating pharmacies to promote the program
•
Links on producers web-sites to the HPSA web site directing traffic to our searchable database of
pharmacies with an explanation of products accepted by the programs.
•
In May 2013, HPSA co-sponsored The Prescription Drug Drop-Off Event with the Ontario
Association of Chiefs of Police, the Ontario Pharmacists Association and the Ontario Provincial
Police as part of a national prescription drug take back initiative for the public to bring their
unused, unwanted and expired prescription drugs/narcotics in a safe and environmentally
responsible manner to different collection sites in Ontario.
Retail Pharmacies:
•
E-newsletter distributed to collection network (appendix 7b)
•
Three fax blasts sent to registered retail pharmacies on the OSCP and the OMRP.
•
Chain pharmacies also distributed this information through their internal networks.
•
Introductory kits sent to all retail pharmacies.
•
Outreach through trade associations to spread awareness.
•
Program information available to pharmacy staff.
•
Chains drug stores fully engaged in meeting participation targets.
Page 24.
Collection Summary (first 6 months of HPSA administration of the OSCP and the OMRP)
•
Medication pails and boxes of sharps containers collected increased 13% (6,204 units).
•
Medications collected increased 10% (21,229 kgs).
•
Biomedical sharps collected increased 10% (11,895 kgs).
•
Cytotoxic sharps collected increased 17% (1,128 kgs).
Program performance summary
•
HPSA has leveraged experience as a national IFO to deliver promotion and education, material
collection and compliance in Ontario.
•
This was done on a very compressed time table with a level of promotion far exceeding what has
previously been done.
•
Member producers have been engaged, active and supportive.
•
Retail pharmacies have continued to support the programs acting as voluntary collection sites.
•
Consumers have been returning increasing amounts of sharps and medications (appendix 8).
•
Commercial agreement with the collector/processor is in place and functioning well. HPSA is
now driving efficiencies into the collection process.
Next Steps
•
HPSA would like to work with other organizations such as RCO, AMO to build on this
momentum and promote the OSCP and OMRP at municipal HHW depots and events where
sharps and medications are currently collected.
Page 25.
Appendix 7a. Promotion and Education - Public
Page 26.
Appendix 7b. Promotion and Education - Pharmacists
Page 27.
Appendix 8. Collection Summary
Page 28.

Interim Report - Health Products Stewardship Association

Transcription

Similar documents

poolplayers.ca - CPA Southern Ontario

Playdium is pleased to present our new Education Program

Recycling Bloopers

Group of Seven in Ontario Parks

Five Star News

Section A2 - Event Advertisement

Technical Writing

September 2015 - Logan County Department of Public Health

Pharmacy Interactive Windows

Ontario`s Forest Bioeconomy

program plan for the ontario sharps collection program may 2013